OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis
Yi Luo, Hongyi Jiang, Weibo Xu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 36
Yi Luo, Hongyi Jiang, Weibo Xu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
BRAF mutations in thyroid cancer
Rafael Selbach Scheffel, José Miguel Dora, Ana Luiza Maia
Current Opinion in Oncology (2021) Vol. 34, Iss. 1, pp. 9-18
Closed Access | Times Cited: 60
Rafael Selbach Scheffel, José Miguel Dora, Ana Luiza Maia
Current Opinion in Oncology (2021) Vol. 34, Iss. 1, pp. 9-18
Closed Access | Times Cited: 60
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Louise Schubert, A. M. Mbekwe-Yepnang, Johanna Wassermann, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1573-1581
Open Access | Times Cited: 7
Louise Schubert, A. M. Mbekwe-Yepnang, Johanna Wassermann, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1573-1581
Open Access | Times Cited: 7
<i>TERT</i> promoter mutations in thyroid cancer
Michiko Matsuse, Norisato Mitsutake
Endocrine Journal (2023) Vol. 70, Iss. 11, pp. 1035-1049
Open Access | Times Cited: 14
Michiko Matsuse, Norisato Mitsutake
Endocrine Journal (2023) Vol. 70, Iss. 11, pp. 1035-1049
Open Access | Times Cited: 14
Clinical and Histopathological Risk Factors for Radioactive Iodine–Refractory Follicular and Oncocytic Thyroid Carcinoma
Merel T Stegenga, Evert F.S. van Velsen, Lindsey Oudijk, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2334-e2341
Open Access | Times Cited: 5
Merel T Stegenga, Evert F.S. van Velsen, Lindsey Oudijk, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2334-e2341
Open Access | Times Cited: 5
Strategies for Radioiodine Treatment: What’s New
Clotilde Sparano, Sophie Moog, Julien Hadoux, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3800-3800
Open Access | Times Cited: 20
Clotilde Sparano, Sophie Moog, Julien Hadoux, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3800-3800
Open Access | Times Cited: 20
A user-friendly nomogram for predicting radioiodine refractory differentiated thyroid cancer
Chao Meng, Juanjuan Song, Long Wen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Chao Meng, Juanjuan Song, Long Wen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review
Călin Muntean, Adelaida Solomon, Remus Călin Cipăian, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 338-338
Open Access
Călin Muntean, Adelaida Solomon, Remus Călin Cipăian, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 338-338
Open Access
The ability of anexelekto (AXL) expression and TERT promoter mutation to predict radioiodine-refractory differentiated thyroid carcinoma
Hasrayati Agustina, Tutik Nur Ayni, Yohana Azhar, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access
Hasrayati Agustina, Tutik Nur Ayni, Yohana Azhar, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access
DNA repair pathway activation features in follicular and papillary thyroid tumors, interrogated using 95 experimental RNA sequencing profiles
Uliana Vladimirova, Pavel O. Rumiantsev, Marianna Zolotovskaia, et al.
Heliyon (2021) Vol. 7, Iss. 3, pp. e06408-e06408
Open Access | Times Cited: 24
Uliana Vladimirova, Pavel O. Rumiantsev, Marianna Zolotovskaia, et al.
Heliyon (2021) Vol. 7, Iss. 3, pp. e06408-e06408
Open Access | Times Cited: 24
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 5. Evaluation of Recurrence Risk Postoperatively and Initial Risk Stratification in Differentiated Thyroid Cancer 2024
Eun Kyung Lee, Young Shin Song, Ho‐Cheol Kang, et al.
International Journal of Thyroidology (2024) Vol. 17, Iss. 1, pp. 68-96
Open Access | Times Cited: 3
Eun Kyung Lee, Young Shin Song, Ho‐Cheol Kang, et al.
International Journal of Thyroidology (2024) Vol. 17, Iss. 1, pp. 68-96
Open Access | Times Cited: 3
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
Petra Petranović Ovčariček, Alfredo Campennì, Bart de Keizer, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4290-4290
Open Access | Times Cited: 9
Petra Petranović Ovčariček, Alfredo Campennì, Bart de Keizer, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4290-4290
Open Access | Times Cited: 9
Clinicopathological Implications of the BRAFV600E Mutation in Papillary Thyroid Carcinoma of Ukrainian Patients Exposed to the Chernobyl Radiation in Childhood: A Study for 30 Years After the Accident
Liudmyla Zurnadzhy, Bogdanova Ti, Tatiana Rogounovitch, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Liudmyla Zurnadzhy, Bogdanova Ti, Tatiana Rogounovitch, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study
Ye Liu, Yuhua Wang, Wanchun Zhang
EJNMMI Research (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Ye Liu, Yuhua Wang, Wanchun Zhang
EJNMMI Research (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?
Noha Mukhtar, Kheloud M. Alhamoudi, Meshael Alswailem, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Noha Mukhtar, Kheloud M. Alhamoudi, Meshael Alswailem, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Blood Profiles in the Prediction of Radioiodine Refractory Papillary Thyroid Cancer: A Case–Control Study
Hanqing Liu, Qian Chen, Bohao Liu, et al.
Journal of Multidisciplinary Healthcare (2023) Vol. Volume 16, pp. 535-546
Open Access | Times Cited: 5
Hanqing Liu, Qian Chen, Bohao Liu, et al.
Journal of Multidisciplinary Healthcare (2023) Vol. Volume 16, pp. 535-546
Open Access | Times Cited: 5
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis
Daniel A. Hescheler, Burkhard Riemann, Milan Hartmann, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 12
Daniel A. Hescheler, Burkhard Riemann, Milan Hartmann, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 12
Predictive Value of Clinical and Pathological Characteristics for Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma: A 16-year Retrospective Study
Jinyan Chai, Ruiguo Zhang, Wei Zheng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 8
Jinyan Chai, Ruiguo Zhang, Wei Zheng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 8
Clinicopathological features of differentiated thyroid carcinoma as predictors of the effects of radioactive iodine therapy
Wen Liu, Beibei Jiang, Jingli Xue, et al.
Annals of Diagnostic Pathology (2023) Vol. 69, pp. 152243-152243
Closed Access | Times Cited: 4
Wen Liu, Beibei Jiang, Jingli Xue, et al.
Annals of Diagnostic Pathology (2023) Vol. 69, pp. 152243-152243
Closed Access | Times Cited: 4
Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors
Bogdanova Ti, Tatiana Rogounovitch, Liudmyla Zurnadzhy, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 1
Bogdanova Ti, Tatiana Rogounovitch, Liudmyla Zurnadzhy, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 1
The value of preoperative molecular testing in the management of Bethesda V and Bethesda VI thyroid tumors
Άννα Πασπάλα, Georgia Bompetsi, Stavroula Α. Paschou, et al.
HORMONES (2024)
Closed Access | Times Cited: 1
Άννα Πασπάλα, Georgia Bompetsi, Stavroula Α. Paschou, et al.
HORMONES (2024)
Closed Access | Times Cited: 1
TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer
Gongxun Tan, Bingquan Jin, Xiaoqin Qian, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Gongxun Tan, Bingquan Jin, Xiaoqin Qian, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Advances in Detecting Low Prevalence Somatic TERT Promoter Mutations in Papillary Thyroid Carcinoma
Vitor Rodrigues da Costa, Larissa Valdemarin Bim, Luiza Dornelles Penteado Pacheco e Silva, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 9
Vitor Rodrigues da Costa, Larissa Valdemarin Bim, Luiza Dornelles Penteado Pacheco e Silva, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 9
Delayed Initial Radioiodine Adjuvant Therapy Does Affect Biochemical Response in Intermediate- to High-Risk Differentiated Thyroid Cancer
Feng Yu, Xue Li, Yanhui Ji, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 9
Feng Yu, Xue Li, Yanhui Ji, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 9
ACR TI-RADS classification combined with number of nodules, halo features optimizes diagnosis and prediction of follicular thyroid cancer
Shi-Ji Wu, Long Tan, Jingliang Ruan, et al.
Clinical Hemorheology and Microcirculation (2022) Vol. 82, Iss. 4, pp. 323-334
Closed Access | Times Cited: 5
Shi-Ji Wu, Long Tan, Jingliang Ruan, et al.
Clinical Hemorheology and Microcirculation (2022) Vol. 82, Iss. 4, pp. 323-334
Closed Access | Times Cited: 5
Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters
Selin Soyluoğlu, Ebru Taştekin, Burak Andac, et al.
Cureus (2023)
Open Access | Times Cited: 2
Selin Soyluoğlu, Ebru Taştekin, Burak Andac, et al.
Cureus (2023)
Open Access | Times Cited: 2
